Report Code: A03852 | Pages: NA | Jul 2023 | 5862 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Restriction Endonucleases Market
Request Now !Restriction endonucleases, also known as restriction enzymes, are possess the capability of cutting through a DNA molecule at a given location. These enzymes form the key component of DNA recombinant technology, and are used to scan a DNA molecule for searching specific sequences that commonly comprise of six or four nucleotides. After locating the required DNA sequences, the restriction endonucleases cut the strand, a process which is known at enzyme digestion.
The factors that drive the growth of the restriction endonucleases market are increase in use of restriction endonucleases in various applications such as in vivo gene editing, epigenetic modifications, building DNA libraries, and others. In addition, rise in investment in R&D activities of molecular biology procedures and techniques fuels the market growth. However, high cost of restriction endonucleases production and certain level of unreliability of these enzymes in providing accuracy restrain the market growth. Conversely, well-established molecular biology industry in developed regions such as North America and Europe is anticipated to provide lucrative growth opportunities for the market.
The report segments the restriction endonucleases market based on application, end user, and region. On the basis of application, the market is categorized into polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), epigenetics, restriction digestion, sequencing, and cloning. In terms of end user, it is classified into hospitals, academic research institutes, pharmaceutical, biotechnology companies, diagnostic centers, and clinics. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global restriction endonucleases market are Promega Corporation, ThermoFisher Scientific, Inc., Agilent Technologies, Inc., Genetix Biotech Asia Pvt. Ltd., Inc., New England Biolabs, Affymetrix, Inc., Illumina, Inc., Enzymatics, Inc., Takara Bio, Inc., and Sigma-Aldrich Co. LLC.
Key Benefits
Restriction Endonucleases Market Report Highlights
Aspects | Details |
---|---|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Promega Corporation, Genetix Biotech Asia Pvt. Ltd., Inc., Illumina, Inc., Takara Bio, Inc., Enzymatics, Inc., Sigma-Aldrich Co. LLC., Agilent Technologies, Inc., Affymetrix, Inc., ThermoFisher Scientific, Inc., New England Biolabs |
Loading Table Of Content...
Start reading.
This Report and over 54,961+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers